Service Hotline: 400-826- 0806

News center


Paradise Silicon Valley and Beida Fund reached a strategic cooperation to help biomedical industry i

Date: 2019-04-26
Views: 25

On April 25, 2019, the 2019 Beida Biomedical Investment and Development Forum was held in Yuhang, Hangzhou. The event gathered industry elites, discussed the investment and development hotspots of the bio-pharmaceutical industry, took the initiative to grasp the new trends and new trends of industrial development, and helped the innovation and development of the bio-pharmaceutical industry. He Xiangdong, chairman of Paradise Silicon Valley, and Wang Hongbin, managing partner, attended the signing ceremony. 


The development of the industry is inseparable from the support of government policies. The State Council has issued a series of documents such as “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry” and “Outline of the “Healthy China 2030” Plan” to guide and encourage the innovative development of the biomedical industry. . Zhou Jianhua, deputy head of Yuhang District People's Government, said in his speech that Yuhang District develops a large health industry and develops a platform, relying on provincial biomedical high-tech industrial park, international life science and technology town, China-Israel International Medical Health Industrial Park, and future technology. Industrial platforms such as City Health Valley have formed a situation in which enterprise agglomeration, innovation accelerates and emerging formats continue to emerge. Yuhang District adopts the park operation mode of “Space + Professional Operator Ten Funds” to create a comfortable living environment for talents and build an optimal entrepreneurial platform.


In the speech of the forum, Dr. Ding Liming, Chairman and CEO of Beida Pharmaceutical, said that in the past years, Beida Pharmaceutical has been striving to help the industrialization of innovative projects and help scientists realize their dream of starting a business while accelerating their own development. With the strong support of the Yuhang District Committee and Government, Beida established the Beida Dream Workshop to build a professional bio-pharmaceutical industry incubator park to provide comprehensive support for innovative and entrepreneurial projects. At the same time, it led the establishment of the Beida Biomedical Industry Fund. Dr. Ding hopes that the Beida Fund will take this cooperation as an opportunity to start, cooperate in a wider range of fields and more projects, and strive to develop more affordable and affordable medicines for the people and promote Yuhang. The pharmaceutical industry has achieved deeper changes and higher quality development, and jointly reached the original intention of cooperation and win-win.


In this forum, Beida Biomedical Industry Fund, Hangzhou Yuhang Financial Holding Group Co., Ltd., Paradise Silicon Valley Asset Management Group Co., Ltd., Hangzhou Bank Co., Ltd., Zhejiang Zheshang Innovation Capital Management Co., Ltd., Hangzhou Hi-Tech Investment Co., Ltd. The company, Yanyuan Capital Group and Zhejiang Dream Town Investment Development Co., Ltd. jointly signed the 'Strategic Cooperation Agreement', reached strategic cooperation, established strategic partnerships, and jointly committed to help the development of biomedical innovation projects.




In the roundtable forum with the theme of “Integration of Industry and Finance, Innovation and Innovation”, Dr. Ding Liming, Chairman and CEO of Beida Pharmaceutical, Chen Guojian, Vice Chairman of Yuhang Financial Group, He Xiangdong, Chairman of Paradise Silicon Valley, and Zheshang Innovation President Zhang Bin, Zhou Gaobing, chairman of Hangzhou Gaotou, and Liu Zeng, president of Yanyuan Capital Group, had a heated discussion on how capital can help biomedical innovation. In the future, under the general environment of government policy reform and support, more outstanding scientists will return to China to innovate and start businesses, and industrial capital can better assist in the transformation of scientific research results. The event hopes to gather the synergy between financial capital and industrial capital to jointly create an innovative future for China's biomedical industry.

News / Related news More
2017 - 12 - 04
Yongquan Forum and Baishaquan · ZUFE Strategic Cooperation Signing Ceremony were held on the afternoon of 3rd December at Baishaquan M&A Block. Yongquan Forum is a major communication and project paring brand created by Baishaquan M&A Block. By hold sharing session and salon or giving speech each month, the forum serves as a communication platform for industry leaders with certai...
2017 - 11 - 30
CAI Gangqing, president and deputy secretary of the Party Committee of Anji Industrial Investment Development Group (IIDG) paid a visit to TTGG with 5 colleagues on the afternoon of 30th November. ZOU Jin, general manager and deputy secretary of the Party Committee of IIDG, FANG Jun, vice-general manager, and other department heads of IIDG attended the discussion. Our managing partner ZHANG Y...
2017 - 11 - 28
Zvi Heifetz, Israeli Ambassador to China, paid a visit to TTGG along with his wife on the evening of 28th November 2017. They were greeted by TTGG’s president YU Baohong. ZHANG Yu and GUO Feng, managing partners of TTGG, LI Xiang, general-manager of Investment Management Department, and other department heads also took part in the meeting.After greeting, YU briefly introduced TTGG’s hist...
2017 - 08 - 14
With the accelerating rhythm of the society, more and more white-collars are feeling stressed under modern work environments. In fact, such stress primarily results from the target-oriented time management. The key factors facilitating their abilities to improve time management efficiency and effectiveness are: how to find the causes of inefficiency, how to distinguish between the important things...
Copyright © 2016 - 2019 Zhejiang Paradise Silicon Valley Asset Management Group Co., Ltd










  • 400-826-0806